Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 17;2(6):1122-1131.
doi: 10.1016/j.ekir.2017.07.001. eCollection 2017 Nov.

Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease

Affiliations

Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease

Patrick H Pun et al. Kidney Int Rep. .

Abstract

Introduction: Chronic kidney disease (CKD) patients have increased risks of sudden cardiac arrest and sudden cardiac death (SCA/SCD) that are not explained by traditional risk factors. We examined associations between serum potassium and SCA/SCD in a large cohort of patients with coronary artery disease (CAD) and moderate CKD.

Methods: Among 22,009 patients who underwent cardiac catheterization at our institution between 1999 and 2011, 6181 patients had an estimated glomerular filtration rate of ≤60 ml/min per 1.73 m2 and were not receiving renal replacement therapy. The risk of SCA/SCD and all-cause mortality associated with potassium concentration was evaluated at the time of cardiac catheterization (baseline) and most proximate to SCA/SCD events. Covariate-adjusted Cox models were used to examine relationships between baseline potassium measurements and outcomes. A propensity score-matched, case-control design was used to assess risk associations of potassium measurements obtained proximate to SCA events.

Results: In the baseline potassium analysis, compared with levels in the normal range, there was no significant risk association between hyperkalemia (>5 mEq/l) or hypokalemia (<3.5 mEq/l) and SCA/SCD or all-cause death after covariate adjustment. In the proximate potassium analysis, hyperkalemia occurred more frequently than hypokalemia (16.7% vs. 3%), and was associated with a doubling in SCA/SCD risk (adjusted odd ratio: 2.37; 95% confidence interval: 1.33-4.23) whereas there was no significant relationship between hypokalemia and outcome.

Discussion: Among CKD patients with significant CAD, elevated serum potassium levels >5.0 mEq/l are common and are associated with an increased short-term risk of SCA/SCD. Early detection and treatment of hyperkalemia may reduce the high risk of SCD among CKD patients.

Keywords: cardiac arrhythmias; cardiovascular disease; chronic kidney disease; hyperkalemia; hypokalemia; sudden death.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram. eGFR, estimated glomerular filtration rate.
Figure 2
Figure 2
Unadjusted cumulative incidence curves for sudden cardiac death/sudden cardiac arrest (SCD/SCA) according to baseline serum potassium categories. High: >5.0 mEq/l; normal: 3.5 to 5.0 mEq/l; low: <3.5 mEq/l.
Figure 3
Figure 3
Risk of sudden cardiac death/sudden cardiac arrest according to the last recorded serum potassium value before the event. Odds ratio estimates are shown with 95% confidence intervals (CI) within each serum potassium category. *Adjusted for ejection fraction, congestive heart failure severity, and proportion of patients who underwent coronary artery bypass grafting after catheterization.

References

    1. Pun P.H., Smarz T.R., Honeycutt E.F. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int. 2009;76:652–658. - PMC - PubMed
    1. Pun P.H., Middleton J.P. Sudden cardiac death in hemodialysis patients: a comprehensive care approach to reduce risk. Blood Purif. 2012;33:183–189. - PubMed
    1. Einhorn L.M., Zhan M., Hsu V.D. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med. 2009;169:1156–1162. - PMC - PubMed
    1. Palmer B.F. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351:585–592. - PubMed
    1. Luo J., Brunelli S.M., Jensen D.E. Association between serum potassium and outcomes in patients with reduced kidney function. Clin J Am Soc Nephrol. 2016;11:90–100. - PMC - PubMed